Montell GM, López-García L, Saint-Martín MM, Cano RC

Idioma: Español
Referencias bibliográficas: 20
Paginas: 272-275
Archivo PDF: 349.88 Kb.

RESUMEN

El síndrome de Sneddon se caracteriza por eventos vasculares cerebrales isquémicos que se relacionan por la presencia de livedo racemosa asociado con anticuerpos antifosfolípidos, hipertensión arterial, crisis convulsivas y valvulopatías cardiacas. Es una enfermedad muy poco frecuente y de mal pronóstico, y su fisiopatología no se conoce con certeza. Presentamos el caso de una mujer de 32 años quien fuera atendida en el Servicio de Medicina Interna del Hospital Centro Médico ABC porque presentaba signos y síntomas clásicos de este síndrome.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Sneddon IB. Cerebrovascular lesions and livedo reticularis. Br J Dermatol. 1965; 77: 180-85.

2. Daoud MS, Wilmoth GJ, Su D, Pittelkow MR. Sneddon syndrome. Semin Dermat. 1995; 14: 166-72.

3. Tietjen GE, Al Quasmi MM, Shukairy MS. Livedo reticularis and migraine: a marker for stroke risk? Headache. 2002; 42: 352-5.

4. Tourbah A, Piette JC, Iba-Zizen MT, Lyon-Caen O, Goudeau P, Frances C. The natural course of cerebral lesions in Sneddon’s syndrome. Arch Neurol. 1997; 54: 53-60.

5. Frances C, Papo T, Wechsler B, Laporte JL, Biousse V, Piette JC. Sneddon syndrome with or without anti-phospholipid Antibodies: A comparative study in 46 Patients. Medicine. 1999; 78 (4): 209-219.

6. Zelger B, Sepp N, Stockhammer G, Dosch E, Hilty E, Ofner D et al. Sneddon’s syndrome. A long term follow up of 25 patients. Arch Dermatol. 1993; 129: 437-47.

7. Kalashnikova LA, Nasonov EL, Borisenko VV, Usman VB, Prudnikova LZ, Kovaljov et al. Sneddon’s syndrome: Cardiac pathology and antiphospholipid antibodies. Clin Exp Rheumatol. 1991; 9: 357-61.

8. Bolayir E, Yilmaz A, Kugu N, Erdogan H, Akyol M, Akyuz A. Sneddon’s syndrome: clinical and laboratory analysis of 10 cases. Acta Med Okayama. 2004; 58 (2): 59-65.

9. Kraemer M, Linden D, Berlit P. The spectrum of differential diagnosis in neurological patients with livedo reticularis and livedo racemosa. A literature review. J Neurol. 2005; 252: 1155-1166.

10. Da Silva AM, Rocha N, Pinto M, Alves V, Farinha F, Correia AP. Tremor as the first neurological manifestation of Sneddon’s syndrome. Mov Disord. 2005; 20 (2): 248-51.

11. Floel A, Imai T, Lohmann H, Bethke F, Sunderkotter C, Droste DW. Therapy of Sneddon syndrome. Eur Neurol. 2002; 48: 126-32.

12. Daoud MS, Wilmoth GJ, Su WP, Pittelkow. Sneddon syndrome. Semin Dermat. 1995; 14: 166-72.

13. Stockhammer G, Felber SR, Zelger B, Sepp N, Birbamer GC, Fritsch PO et al. Sneddon’s syndrome: diagnosis by skin biopsy and MRI in 17 patients. Stroke. 1993; 24: 685-90.

14. Antoine JC, Michel D, Gamier P, Genin C. Rheumatic hearts disease and Sneddon’s syndrome. Stroke. 1994; 25: 689-91.

15. Koner O, Gunay I, Cetin G, Celebi S. Mitral valve replacement in a patient with Sneddon’s syndrome. J Cardiothorac Vasc Anesth. 2005; 19 (5): 661-4.

16. Geschwind DH, Fitzpatrick M, Mischel PS, Cummings JL. Sneddon’s syndrome is a thrombotic vasculopathy: neuropathologic and neuroradiologic evidence. Neurology. 1995; 45: 557-560.

17. Sitzer M, Songher D, Siebler M, Specker C, Rademacher J, Janda I et al. Cerebral microembolism in patients with Sneddon’s syndrome. Arch Neurol. 1995; 52: 271-75.

18. Zelger B, Sepp N, Schmid KW, Hinter H, Klein G, Fritsch PO. Life history of cutaneous vascular lesions in Sneddon’s syndrome. Hum Pathol. 1992; 23: 668-75.

19. Sepp N, Zelger B, Schuler G, Romani N, Fritsch P. Sneddon’s syndrome. An inflammatory disorder of small arteries followed by smooth muscle proliferation. Immuno-histochemical and ultrastructural evidence. Am J Surg Pathol. 1995; 19: 448-53.

20. Sepp N, Zelger B, Schuler G, Romani N, Fritsch P. Sneddon’s syndrome-an inflammatory disorder of small arteries followed by smooth muscle proliferation. Am J Surg Pathol. 1995; 19: 448-453.